Macular degeneration is a leading cause of vision loss, especially in people over the age of 50. It affects the macula, a ...

Toll-like receptors (TLRs) are vital components of the immune system, acting as sentinels that detect and respond to ...

New treatments for macular degeneration may help preserve your eyesight for longer, without the need for frequent injections. Some of these treatments include retinal gene therapy and the "port" ...

A new eye drop therapy offers a non-invasive alternative for treating dry age-related macular degeneration. Massively ...

The FDA has approved a first-of-its-kind treatment for dry age-related macular degeneration (AMD), a leading cause of blindness in adults over 55.

New treatments for macular degeneration may help preserve your eyesight for longer, without the need for frequent injections. Some of these treatments include retinal gene therapy and the "port ...

Since July 2024, faricimab has also been approved in Europe for the treatment of visual impairment due to macular edema ...

and education that can help you adapt to your new situation. It can be a shock to learn that you have a serious medical problem like wet age-related macular degeneration. Realistically, the condition ...

Fresenius, through its operating company Fresenius Kabi, is broadening its growing biopharma portfolio through a new licensing agreement with South Korea’s SamChunDang Pharm. Under the agreement, ...

Astellas Pharma Inc. (ALPMY, ALPMY) announced that the U.S. Food and Drug Administration accepted the revised supplemental New Drug ...

Once the new vessels that can ... increase your chances of developing macular degeneration, consult your healthcare team or eye doctor about testing and treatment. Healthline has strict sourcing ...

Shares of Outlook Therapeutics jumped after the company said it continues to progress the development of its treatment for wet age-related macular degeneration ... said. New data from a current ...